Edition:
India

Fate Therapeutics Inc (FATE.OQ)

FATE.OQ on NASDAQ Stock Exchange Global Market

7.37USD
19 Jan 2018
Change (% chg)

$0.19 (+2.65%)
Prev Close
$7.18
Open
$7.15
Day's High
$7.40
Day's Low
$7.10
Volume
112,410
Avg. Vol
101,534
52-wk High
$7.40
52-wk Low
$2.54

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 1.03 -0.233
Mar '17 1.03 -0.245
FY 2016 Dec '16 1.03 -0.213
Sep '16 1.03 -0.272
Jun '16 1.03 -0.291
Mar '16 1.32 -0.291
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 4 1.03 1.10 1.00 1.00
Quarter Ending Jun-18 4 1.28 2.10 1.00 1.00
Year Ending Dec-18 7 4.95 12.20 2.05 5.41
Earnings (per share)
Quarter Ending Mar-18 4 -0.08 0.39 -0.27 -0.18
Quarter Ending Jun-18 4 -0.05 0.44 -0.24 -0.18
Year Ending Dec-18 7 -0.56 1.67 -1.07 -0.91
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % 81.08 65.50 30.34
EPS (TTM) % 10.46 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Fate Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 70.29%
# of Holders: 101
Total Shares Held: 35,835,776
3 Mo. Net Change: 5,251,298
# New Positions: 2
# Closed Positions: 2
# Increased Positions: 9
# Reduced Positions: 3
# Net Buyers: 6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.